Dave L Dixon (D L Dixon)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Pharmacotherapy

Pharmacy practice

Diabetes/metabolism research and reviews

Journal of cardiovascular pharmacology

Virginia Commonwealth University School of Pharmacy

Campbell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Virginia Commonwealth University School of Pharmacy Jan 01 2012

United States

Associate Professor :: Pharmacotherapy & Outcomes Science

Education History

Campbell University

United States

PHD

Publications

Natalie J Bohmke, Dave L Dixon, Danielle L Kirkman
Chrono-nutrition for hypertension. Diabetes/metabolism research and reviews 40 (1) (2024)
Dave L Dixon, Salvatore Carbone
Is Metformin Cardioprotective? A New Piece to the Puzzle. Journal of cardiovascular pharmacology 84 (2) (2024)
Ibrahim S Alhomoud, Azita Hajhossein Talasaz, Preethi Chandrasekaran, Roy E Brown, Anurag Mehta, Dave L Dixon
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management. Pharmacotherapy (2024)
Ibrahim S Alhomoud, Azita Talasaz, Anurag Mehta, Michael S Kelly, Evan M Sisson, Audrieanna Browning, Roy Brown, Dave L Dixon
Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease: A Review of Current and Emerging Therapies. Pharmacotherapy (2023)
Stacey Cutrell, Ibrahim S Alhomoud, Anurag Mehta, Azita Hajhossein Talasaz, Benjamin W Van Tassell, Dave L Dixon
ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights. Current hypertension reports (2023)
Dave L Dixon, Hayley E Billingsley, Justin M Canada, Cory R Trankle, Dinesh Kadariya, Richard Cooke, Linda Hart, Benjamin Van Tassell, Antonio Abbate, Salvatore Carbone
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF Study. Journal of cardiovascular pharmacology 78 (3) (2022)
Leo F Buckley, William L Baker, Benjamin W Van Tassell, Jordana B Cohen, Omar S Alkhezi, Adam P Bress, Dave L Dixon
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events. Hypertension (Dallas, Tex. : 1979) (2022)
Azita H Talasaz, Ai-Chen Jane Ho, Fawzia Bhatty, Rachel A Koenig, Dave L Dixon, William L Baker, Benjamin W Van Tassell
Meta-analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD. Pharmacotherapy (2021)
Dave L Dixon, William L Baker, Leo F Buckley, Teresa M Salgado, Benjamin W Van Tassell, Barry L Carter
Effect of a Physician/Pharmacist Collaborative Care Model on Time in Target Range for Systolic Blood Pressure: Post Hoc Analysis of the CAPTION Trial. Hypertension (Dallas, Tex. : 1979) 78 (4) (2021)
Arden R Barry, Dave L Dixon
Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease. Pharmacotherapy (2021)
Dave L Dixon, Evan M Sisson, Lauren G Pamulapati, Rowan Spence, Teresa M Salgado
An ounce of prevention is worth a pound of cure: considerations for pharmacists delivering the National Diabetes Prevention Program. Pharmacy practice 19 (2) (2021)
Marco Lombardi, Juan G Chiabrando, Giovanni M Vescovo, Edoardo Bressi, Marco Giuseppe Del Buono, Salvatore Carbone, Rachel A Koenig, Benjamin W Van Tassell, Antonio Abbate, Giuseppe Biondi-Zoccai, Dave L Dixon
Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis. Current atherosclerosis reports 22 (9) (2020)
Dave L Dixon, Salvatore Carbone
Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity? Diabetes/metabolism research and reviews 36 (6) (2020)
Salvatore Carbone, Hayley E Billingsley, Justin M Canada, Edoardo Bressi, Brando Rotelli, Dinesh Kadariya, Dave L Dixon, Roshanak Markley, Cory R Trankle, Richard Cooke, Krishnasree Rao, Keyur B Shah, Horacio Medina de Chazal, Juan Guido Chiabrando, Alessandra Vecchié, Megan Dell, Virginia L Mihalick, Roberta Bogaev, Linda Hart, Benjamin W Van Tassell, Ross Arena, Francesco S Celi, Antonio Abbate
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study. Diabetes/metabolism research and reviews 36 (8) (2020)
Teresa M Salgado, Meagen M Rosenthal, Antoinette B Coe, Tana N Kaefer, Dave L Dixon, Karen B Farris
Primary healthcare policy and vision for community pharmacy and pharmacists in the United States. Pharmacy practice 18 (3) (2020)
Tyler D Wagner, Morgan C Jones, Teresa M Salgado, Dave L Dixon
Pharmacist's role in hypertension management: a review of key randomized controlled trials. Journal of human hypertension 34 (7) (2020)
Teresa M Salgado, Dave L Dixon
Practice Forum: A new section led by the Center for Pharmacy Practice Innovation at Virginia Commonwealth University School of Pharmacy. Pharmacy practice 17 (1) (2019)
Estela Lajthia, Audrieanna Browning, Pramit A Nadpara, Dave L Dixon, Lauren M Caldas, Michael Murchie, Evan M Sisson
Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series. Pharmacy practice 17 (4) (2019)
Aldo Bonaventura, Salvatore Carbone, Dave L Dixon, A Abbate, Fabrizio Montecucco
Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists. Journal of internal medicine 286 (1) (2019)
Dave L Dixon, Teresa M Salgado, James Matthew Luther, James Brian Byrd
Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services. Journal of clinical hypertension (Greenwich, Conn.) 21 (12) (2019)
Evan M Sisson, Lauren Pamulapati, John D Bucheit, Michael S Kelly, Dave L Dixon
Evolving Role of Non-Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future. Pharmacotherapy 38 (2) (2018)
Sydney L Littauer, Dave L Dixon, Vimal K Mishra, Evan M Sisson, Teresa M Salgado
Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review. Pharmacy practice 15 (4) (2017)
Dave L Dixon, Evan M Sisson, Eric D Parod, Benjamin W Van Tassell, Pramit A Nadpara, Daniel Carl, Alan W Dow
Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population. Journal of clinical hypertension (Greenwich, Conn.) 20 (1) (2017)

Dave L Dixon.css-eqlu8i{font-size:small;padding-left:4px;} (D L Dixon)

Publication Activity (10 Years)

Top Topics

Top Venues

Dave L Dixon (D L Dixon)